TREA

79205165 - DRAINHUNT

Follow

Information

  • Trademark
  • 79205165
  • Serial Number
    79205165
  • Registration Number
    5388879
  • Filing Date
    September 30, 2016
    8 years ago
  • Registration Date
    January 30, 2018
    6 years ago
  • Transaction Date
    September 24, 2024
    a month ago
  • Status Date
    August 16, 2024
    3 months ago
  • Published for Opposition Date
    November 14, 2017
    7 years ago
  • Location Date
    January 30, 2018
    6 years ago
  • Status Code
    709
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    CHANG, BETTY
  • Attorney Docket Number
    61459.4000
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
4
Mark Identification
DRAINHUNT
Case File Statements
  • GS0051: Biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for use in neurodegenerative diseases; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for use in trinucleotide repeat disorders, in particular for use in Huntington's Chorea; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for preventing neurodegenerative diseases; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for preventing trinucleotide repeat disorders, in particular for preventing Huntington's Chorea; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for the treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for the treatment of trinucleotide repeat disorders, in particular for the treatment of Huntington'a chorea; biochemical and chemical preparations for medical purposes in oral administration forms, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in oral administration forms, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of trinucleotide repeat disorders; biochemical and chemical preparations for medical purposes in oral administration forms, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of Huntington's Chorea; biochemical and chemical preparations for medical purposes in parenteral administration forms, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in parenteral administration forms, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of trinucleotide repeat disorders; biochemical and chemical preparations for medical purposes in parenteral administration forms, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of Huntington's chorea
  • PM0001: DRAIN HUNT
  • GS0011: Chemical products for the production of viral, retroviral and non-viral vectors
Case File Event Statements
  • 4/15/2017 - 7 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/13/2017 - 7 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 4/15/2017 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/15/2017 - 7 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/16/2017 - 7 years ago
    5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 4/19/2017 - 7 years ago
    6 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 4/19/2017 - 7 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 4/19/2017 - 7 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 5/5/2017 - 7 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNP
  • 9/19/2017 - 7 years ago
    10 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/20/2017 - 7 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/25/2017 - 7 years ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/14/2017 - 7 years ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/14/2017 - 7 years ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/30/2018 - 6 years ago
    19 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/30/2018 - 6 years ago
    20 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 5/2/2018 - 6 years ago
    21 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 9/19/2017 - 7 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/19/2017 - 7 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/23/2017 - 7 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/9/2017 - 7 years ago
    15 - ASSIGNED TO LIE Type: ALIE
  • 1/30/2023 - a year ago
    27 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 8/16/2024 - 3 months ago
    28 - CANCELLED SECTION 71 Type: C71T
  • 3/11/2022 - 2 years ago
    26 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 5/2/2018 - 6 years ago
    22 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 6/8/2018 - 6 years ago
    23 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 11/12/2021 - 3 years ago
    24 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 3/11/2022 - 2 years ago
    25 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP